Combining TIGIT Blockade with MDSC Inhibition Hinders Breast Cancer Bone Metastasis by Activating Antitumor Immunity.

Overview of attention for article published in Cancer Discovery, March 2024

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

So far, Altmetric has seen 122 X posts from 80 X users, with an upper bound of 662,230 followers.

Thank you so much @MorrealeBrian for this cool summary of our study! https://t.co/hHUIP9A0Qe

RT @MorrealeBrian: Never thought I’d make a short video summarizing an exciting immunotherapy paper! Thank you ⁦⁦@JuliaBauman2⁩ for all you…

RT @InnovOncology: Combining TIGIT Blockade with MDSC Inhibition Hinders Breast Cancer Bone Metastasis by Activating Antitumor Immunity @C…

Combining TIGIT Blockade with MDSC Inhibition Hinders Breast Cancer Bone Metastasis by Activating Antitumor Immunity @CD_AACR @ElizSMcKenna @NCIDirector @SyedAAhmad5 @ArndtVogel @HarmonyTurk @News_TIA #InnoConf24 https://t.co/gYTMu8PWJs

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 118 additional X posts.